Ondine President increases shareholding | 06-Feb-2025 | 11:00 | RNS |
Ondine CEO increases shareholding | 04-Feb-2025 | 08:30 | RNS |
Ondine CEO increases ownership | 03-Feb-2025 | 08:00 | RNS |
Appointment of Nominated and Financial Adviser | 03-Feb-2025 | 07:00 | RNS |
CEO Increases Stake in Ondine | 31-Jan-2025 | 10:03 | RNS |
Replacement: Director Increases Stake in Ondine | 31-Jan-2025 | 09:52 | RNS |
Director Increases Stake in Ondine | 31-Jan-2025 | 07:00 | RNS |
Notification of Major Holdings | 30-Jan-2025 | 17:49 | RNS |
Notification of Major Holdings | 29-Jan-2025 | 17:00 | RNS |
Grant of Options and Warrants | 29-Jan-2025 | 07:15 | RNS |
HCA to invest US$4 million in Ondine | 27-Jan-2025 | 07:00 | RNS |
Ondine recruits first patient for US Phase 3 trial | 30-Dec-2024 | 07:00 | RNS |
Ondine commencing US Phase 3 clinical trial | 17-Dec-2024 | 07:00 | RNS |
Notification of Major Holdings | 25-Nov-2024 | 17:00 | RNS |
Notification of Major Holdings | 22-Nov-2024 | 10:31 | RNS |
Currency | UK Pounds |
Share Price | 14.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 14.50 |
52 Week Low | 5.63 |
Volume | 5,992 |
Shares Issued | 443.43m |
Market Cap | £63.19m |
Beta | 0.06 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
13:29 | 992 @ 14.36p |
09:44 | 5,000 @ 14.37p |
Chair | Jean Charest |
CEO | Carolyn Cross |
You are here: research